|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/6883 |
| (11) | Patento numeris | 3140313 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15789810.7 |
| Europos patento paraiškos padavimo data | 2015-05-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-03-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-02-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/029040 |
| Data | 2015-05-04 |
| (87) | Numeris | WO 2015/171493 |
| Data | 2015-11-12 |
| (30) | Numeris | Data | Šalis |
| 201461988293 P | 2014-05-04 | US | |
| 201461988841 P | 2014-05-05 | US | |
| 201462036085 P | 2014-08-11 | US | |
| 201562135658 P | 2015-03-19 | US |
| (72) |
GOLDEN, Pam, US
FODOR, Anthony, US
BORTEY, Enoch, US
FORBES, William, US
|
| (73) |
Salix Pharmaceuticals, Inc.,
400 Somerset Corporate Boulevard, Bridgewater, NJ 08807,
US
|
| (54) | IBS MICROBIOTA AND USES THEREOF |
| IBS MICROBIOTA AND USES THEREOF |